What Do We Mean When We Say ‘Such and Such a Problem Costs the Economy £XXm per Annum’?

When we treat a disease it has a net marginal cost – we will call it A, and assume it is positive, i.e. it costs the health service more than the counter-factual. It also has a benefit, measured perhaps in Quality-Adjusted Life Years (QALYs) or Disability-Adjusted Life Years (DALYs). A cost per DALY can then be calculated. If we know the value of a QALY (£20m in England, for example), then we can calculate the expected benefit in monetary terms. In England, an intervention providing an incremental 2.5 QALYs would represent a monetary value of 2.5 x 20 = £50k – call that B. Then the Expected Net Benefit is BA; if the intervention has net mean costs of £30k per patient, then the ENB is £20k.

What’s wrong with that? Well nothing, unless the treatment is life-saving. In that case, insofar as the new treatment is effective, some patients who would have died now survive to generate health costs in the future. So strictly speaking the downstream (discounted) cost, C, should be included, so that Expected Net Benefit is BAC. This is never done, perhaps because it makes the dismal science just too dismal. In the case of individual clinical treatments alternative uses of the money may involve a treatment that saves a similar proportion of life years so downstream costs can be ‘pruned’. If not, then the treatment that saves more lives gets penalised, which seems wrong even if it is logical within the paradigm. But clinical treatments are one thing, calculating the societal cost of a disease is another. Here it seems particularly wrong to ignore downstream contingent costs unless these are very remote (say over 50 years), in which case discounting takes care of them. It is common, for example, for public health academics to claim that public health interventions, such as reducing salt or sugar in the diet, would save £XX million per year. Yet these calculations exaggerate returns to society because the costs of looking after survivors are ignored in the calculations. Many public health interventions would still be a very good investment even if downstream costs were included. So there is no need to exaggerate the benefit by ignoring downstream costs contingent on earlier deaths avoided.

— Richard Lilford, CLAHRC WM Director

One thought on “What Do We Mean When We Say ‘Such and Such a Problem Costs the Economy £XXm per Annum’?”

  1. Just as it is deceptive to talk of ‘investing’ e.g. in a new hospital with en suite individual rooms instead of shared rooms, when what we are really doing is ‘spending tax -payers money’ on expensive higher quality facilities,
    So also it would make for much greater clarity of thinking for us all if we ban all talk about ‘saving lives’ when all such treatments are in plain English ‘postponing death’ Then perhaps we will hear less about new management options which are promised will “saving tax-payers” money, when over the next few years they will clearly cost the NHS budget a great deal more not less. Pedantic maybe but a useful reminder of reality for the general public.

    As this weeks Private Eye cartoon put it
    “But, doctor, what are the advantages of living longer?”

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s